Correlation Between Lipella Pharmaceuticals and Ascletis Pharma
Can any of the company-specific risk be diversified away by investing in both Lipella Pharmaceuticals and Ascletis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipella Pharmaceuticals and Ascletis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lipella Pharmaceuticals Common and Ascletis Pharma, you can compare the effects of market volatilities on Lipella Pharmaceuticals and Ascletis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipella Pharmaceuticals with a short position of Ascletis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipella Pharmaceuticals and Ascletis Pharma.
Diversification Opportunities for Lipella Pharmaceuticals and Ascletis Pharma
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Lipella and Ascletis is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Lipella Pharmaceuticals Common and Ascletis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ascletis Pharma and Lipella Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipella Pharmaceuticals Common are associated (or correlated) with Ascletis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ascletis Pharma has no effect on the direction of Lipella Pharmaceuticals i.e., Lipella Pharmaceuticals and Ascletis Pharma go up and down completely randomly.
Pair Corralation between Lipella Pharmaceuticals and Ascletis Pharma
Given the investment horizon of 90 days Lipella Pharmaceuticals is expected to generate 4.2 times less return on investment than Ascletis Pharma. In addition to that, Lipella Pharmaceuticals is 2.96 times more volatile than Ascletis Pharma. It trades about 0.0 of its total potential returns per unit of risk. Ascletis Pharma is currently generating about 0.04 per unit of volatility. If you would invest 20.00 in Ascletis Pharma on November 3, 2024 and sell it today you would earn a total of 4.00 from holding Ascletis Pharma or generate 20.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.94% |
| Values | Daily Returns |
Lipella Pharmaceuticals Common vs. Ascletis Pharma
Performance |
| Timeline |
| Lipella Pharmaceuticals |
| Ascletis Pharma |
Lipella Pharmaceuticals and Ascletis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lipella Pharmaceuticals and Ascletis Pharma
The main advantage of trading using opposite Lipella Pharmaceuticals and Ascletis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipella Pharmaceuticals position performs unexpectedly, Ascletis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascletis Pharma will offset losses from the drop in Ascletis Pharma's long position.| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |